Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05219513
Title A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RO7443904 in Combination With Glofitamab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ITA | GBR | FRA | DNK | AUS

Facility Status City State Zip Country Details
MSKCC New York New York 10065 United States Details
Cleveland Clinic Foundation; Hematology and Oncology Cleveland Ohio 44195 United States Details
University of Pennsylvania Philadelphia Pennsylvania 19104 United States Details
Peter MacCallum Cancer Centre; Department of Haematology Melbourne Victoria 3002 Australia Details
Rigshospitalet; Hæmatologisk Klinik, Klinisk Afprøvnings Team KAT København Ø 2100 Denmark Details
CHRU Lille - Hôpital Claude Huriez; Service des Maladies du Sang Lille 59037 France Details
ASST PAPA GIOVANNI XXIII; Ematologia Bergamo Lombardia 24127 Italy Details
Istituto Clinico Humanitas;U.O. Oncologia Medica Ed Ematologia Rozzano Lombardia 20089 Italy Details
Leicester Royal Infirmary; Dept of Haematology Leicester LE1 5WW United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field